BORGIANI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 37.175
AS - Asia 4.136
EU - Europa 3.906
SA - Sud America 595
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 9
Totale 45.907
Nazione #
US - Stati Uniti d'America 37.012
SG - Singapore 1.944
CN - Cina 842
IT - Italia 628
DE - Germania 563
BR - Brasile 499
RU - Federazione Russa 473
UA - Ucraina 453
VN - Vietnam 376
IE - Irlanda 369
FR - Francia 348
HK - Hong Kong 309
PL - Polonia 259
GB - Regno Unito 254
SE - Svezia 179
FI - Finlandia 168
JP - Giappone 133
BD - Bangladesh 112
CA - Canada 96
KR - Corea 94
IN - India 60
NL - Olanda 55
TR - Turchia 45
AR - Argentina 35
BE - Belgio 33
MX - Messico 32
ID - Indonesia 31
ZA - Sudafrica 31
KG - Kirghizistan 29
IR - Iran 23
UZ - Uzbekistan 23
AT - Austria 22
CZ - Repubblica Ceca 21
IQ - Iraq 21
ES - Italia 20
PE - Perù 14
MA - Marocco 13
PK - Pakistan 13
EU - Europa 11
LT - Lituania 10
MY - Malesia 10
CO - Colombia 9
EC - Ecuador 9
CH - Svizzera 8
PY - Paraguay 8
RO - Romania 8
VE - Venezuela 8
AU - Australia 7
CL - Cile 7
NP - Nepal 7
A2 - ???statistics.table.value.countryCode.A2??? 6
DZ - Algeria 6
IL - Israele 6
JM - Giamaica 6
PH - Filippine 6
SA - Arabia Saudita 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
PT - Portogallo 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
SV - El Salvador 4
AL - Albania 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
JO - Giordania 3
QA - Qatar 3
RS - Serbia 3
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
DM - Dominica 2
IS - Islanda 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
Totale 45.892
Città #
Woodbridge 9.832
Wilmington 9.462
Houston 8.593
Fairfield 1.197
Singapore 1.124
Ann Arbor 737
Ashburn 735
Chandler 643
San Jose 471
Seattle 432
New York 391
Cambridge 389
Jacksonville 367
Beijing 352
Dublin 341
Hong Kong 304
Medford 260
Rome 224
Kraków 215
The Dalles 184
Council Bluffs 168
Santa Clara 165
Dallas 162
Dearborn 159
Los Angeles 143
Lawrence 120
Boardman 112
Ho Chi Minh City 107
Tokyo 105
Hanoi 102
Menlo Park 94
Lauterbourg 90
Buffalo 76
Moscow 72
San Diego 61
São Paulo 61
Helsinki 60
Munich 54
London 44
Milan 38
Zhengzhou 37
Chicago 35
Warsaw 34
Redwood City 33
Montreal 30
Palo Alto 30
Orem 29
Atlanta 28
Toronto 28
Norwalk 27
Shanghai 27
Brussels 26
Mülheim 26
Da Nang 25
Nuremberg 25
Phoenix 24
Denver 23
Mountain View 23
North Bergen 23
Frankfurt am Main 22
Hefei 22
Redondo Beach 22
Chennai 21
Jakarta 21
Johannesburg 21
Brooklyn 19
Stockholm 18
University Park 17
Seoul 16
Ankara 15
Poplar 15
Tashkent 15
Haiphong 14
Nanjing 14
San Francisco 14
Amsterdam 13
Belo Horizonte 13
Kunming 13
Lappeenranta 13
Monte Vista 13
Manchester 12
Olomouc 12
Vienna 12
Columbus 11
Detroit 11
Dhaka 11
Hangzhou 11
Hải Dương 11
Istanbul 11
Querétaro 11
Brasília 10
Charlotte 10
Guangzhou 10
Philadelphia 10
Verona 10
Boston 9
Mexico City 9
Rio de Janeiro 9
Turku 9
Baghdad 8
Totale 39.337
Nome #
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 537
High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase 526
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 510
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 503
Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians 496
A family study of asymptomatic small bowel Crohn's disease 495
Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease 492
Age-related macular degeneration: insights into inflammatory genes 491
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 488
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population 487
A Pharmacogenetics Study in Mozambican Patients Treated with Nevirapine: Full Resequencing of TRAF3IP2 Gene Shows a Novel Association with SJS/TEN Susceptibility 486
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 484
Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice 482
Advances in exploring the role of micrornas in inflammatory bowel disease 481
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene 480
CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population 479
Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique 472
Intrauterine development and MNSs blood groups in repeated spontaneous abortion. 472
Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01 469
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 468
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study 467
Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms 466
A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus 462
Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype 459
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons syndrome/toxic epidermal necrolysis susceptibility in a population from Mozambique 456
Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient 456
Crohn's disease, the mycobacterium paratuberculosis and the genetic bond: An unexpected trio 453
Foetal macrosomia and erythrocyte acid phosphatase (ACP1) polymorphism in diabetic and normal pregnancy. 452
Comparative analysis between saliva and buccal swabs as source of DNA: Lesson from HLA-B∗57:01 testing 451
Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction 450
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 450
Interleukin-23R Arg381Gln Is Associated With Susceptibility to Crohn's Disease But Not With Phenotype in an Italian Population 448
Role of genetics in prevention of coronary atherosclerosis 448
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 446
Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome 443
FLG (filaggrin) null mutations and sunlight exposure: Evidence of a correlation 443
Association of the ACP1 genotype with metabolic parameters upon initial diagnosis of type 1 diabetes. 442
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development 440
Biomarkers to predict drug efficacy and safety in neurodegenerative diseases 439
Pharmacogenomics of multifactorial diseases: A focus on psoriatic arthritis 439
Cannabinoid Poisoning by Hemp Seed Oil in a Child 439
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. 438
Association between ACP(1) and favism: A possible biochemical mechanism 436
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 435
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 434
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 434
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis 429
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase 428
Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population 427
Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy 426
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease 426
Diabetic complications and the genetics of signal transduction. A study of retinopathy in NIDDM 425
Phosphotyrosine-protein-phosphatase and diabetic disorders. Further studies on the relationship between low molecular weight acid phosphatase genotype and degree of glycemic control 424
Acid phosphatase locus 1 (ACP1): Possible relationship of allelic variation to body size and human population adaptation to thermal stress - A theoretical perspective 422
Two molecular assays for the rapid and inexpensive detection of GJB2 and GJB6 mutations 422
Identification of two SNPs in the 5' flanking region of the ACP1 gene and evaluation of disequilibrium among polymorphic sites. 421
Recent advances in the genetic susceptibility to osteoarthritis 419
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 419
Neonatal screening, clinical features and genetic testing for galactosemia [3] 417
Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. 416
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 415
MicroRNA genetic variations: association with type 2 diabetes 412
EPHX1 Polymorphisms Are Not Associated With Warfarin Response in an Italian Population 411
ABCC10 rs2125739 polymorphism and nevirapine-induced hepatotoxicity: lack of association in a population from Mozambique 411
IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs 410
Phosphoglucomutase genetic polymorphism of newborns 409
RH blood groups and diabetic disorders: Is there an effect on glycosylated hemoglobin level? 407
A study of human growth hormone and insulin gene regions in relation to metabolic control of non-insulin-dependent diabetes mellitus 405
Genotyping OLR1 gene: A genomic biomarker for cardiovascular diseases 404
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 403
L’impatto sulla salute umana dell’arsenico presente in basse concentrazioni nelle acque. Proposta di uno studio caso controllo Nested nell’area del viterbese 403
Correction: A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics 403
Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction 399
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 398
Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes 396
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 394
OLR1 gene and coronary artery disease/acute myocardial infarction: Replication in an independently collected sample [1] 393
Rh blood groups and diabetic disorders 393
Low molecular weight PTP-IL-4RA interaction in atopy predisposition 390
Genetic tests and genomic biomarkers: regulation, qualification and validation 389
New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases [Nuovi approfondimenti nella ricerca su l'ateroslerosi: LOX-1, un primo attore nelle malattie cardiovascolari] 388
Pharmacogenomics: role in medicines approval and clinical use 386
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 380
Foetal macrosomia in diabetic pregnancy. Further data on the association with maternal PGM1 genotype 372
Pharmacogenetics of inflammatory bowel disease: A focus on Crohn's disease 366
Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility 363
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 362
Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic Studies 360
Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner. 345
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population 332
A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine 324
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 316
Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility 310
Interaction between microbiome and host genetics in psoriatic arthritis 300
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects 292
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes 273
Pharmacogenomics in Parkinson's disease: which perspective for developing a personalized medicine? 267
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 266
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals 258
COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells 221
Totale 41.871
Categoria #
all - tutte 108.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 0 69
2021/20221.359 75 134 60 83 52 145 67 55 125 122 104 337
2022/20231.639 171 142 47 232 158 375 136 91 137 20 85 45
2023/2024843 84 19 40 24 47 327 34 41 12 8 16 191
2024/20252.994 91 671 307 226 59 125 222 181 338 276 228 270
2025/20265.506 498 204 648 542 524 208 691 567 582 540 251 251
Totale 46.436